Clinical Trial Update: A Study of QLS1209 in theTreatment of Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating QLS1209 in patients with advanced solid tumors. The trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• QLS1209

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1 | Status: NOT_YET_RECRUITING